• Mundipharma and Cidara’s rezafungin gets Orphan Drug Designation in EU pharmaceutical-technology
    January 28, 2021
    The European Commission (EC) has adopted the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) recommendation to grant Orphan Drug Designation (ODD) to Mundipharma and Cidara Therapeutics’ rezafungin for treating ...
PharmaSources Customer Service